Skip to main content

Sweden s Global Genomic Licenses Gene-Expression Technology to Danish Biotech Rheoscience

NEW YORK, Sept. 22 (GenomeWeb News) - Global Genomics today said that Danish biotech company Rheoscience will use its tangerine gene expression profiling technology to study targets in metabolic diseases.

 

Global Genomics is based in Stockholm, Sweden. The tangerine technology is based on PCR, capillary electrophoresis, proprietary databases and algorithms that generate gene expression profiles.

 

Financial details of the deal were not disclosed.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.